Sort
39,280 grants matching “leukemia”
NCTN Deep South Research Consortium
$450,954Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2025 · CA
Overcoming ibrutinib resistance in mantle cell lymphoma
$450,951Alexey V. Danilov · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML
$450,915Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL
$450,867Alejandro Gutierrez · Boston Children'S Hospital · R01 · FY2015 · CA
Impact of Leukemia Microenvironment on Response to Targeted Therapies in AML
$450,830Anupriya Agarwal · Oregon Health & Science University · U54 · FY2019 · CA
Role of IL-17 receptor A in aging bone remodeling
$450,806Hicham M Drissi · Emory University · R01 · FY2025 · AG
Targeting microRNAs to eradicate leukemia stem cells
$450,769Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML
$450,740Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
$450,736Paul Michael Armistead · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
An innovative integrated computational framework using gene signatures for patient stratification
$450,696Chao Cheng · Baylor College Of Medicine · R01 · FY2025 · CA
Understanding Richter's Transformation in the targeted therapies era
$450,684Rosa Lapalombella · Ohio State University · R01 · FY2024 · CA
Regulation of MLK3 by LATS
$450,666Deborah N Chadee · University Of Toledo · R15 · FY2019 · CA
Chemical manipulation of creatine kinases to treat acute myeloid leukemia
$450,655Edward Thomas Chouchani · Dana-Farber Cancer Inst · R21 · FY2021 · CA
ETS1-dependent combinatorial control of oncogenic transcription in Notch-activated T-ALL
$450,646Mark Y Chiang · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Improved Targeting Strategies
$450,632Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model
$450,588Lorraine J Gudas · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · AA
Aberrant megakaryopoiesis in the myeloproliferative neoplasms.
$450,538John D Crispino · Northwestern University At Chicago · R01 · FY2019 · HL
Cancer and Leukemia Group B - The Ohio State University
$450,518Clara D Bloomfield · Ohio State University · U10 · FY2008 · CA
Clinical Trials Shared Resource
$450,517Jordan D Berlin · Vanderbilt University · P30 · FY2014 · CA
Mechanisms of targeting cellular self-renewal in glioblastoma
$450,510Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
Single cell growth assay for residual cells in acute lymphoblastic leukemia
$450,496Scott R Manalis · Massachusetts Institute Of Technology · R33 · FY2017 · CA
Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias
$450,484Alejandro Gutierrez · Boston Children'S Hospital · R01 · FY2021 · CA
Development of Chimeric Antigen Receptors Targeting Multiple Myeloma
$450,431James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Targeting the Notch:Myc axis in leukemia/lymphoma
$450,421Warren S Pear · University Of Pennsylvania · R01 · FY2019 · CA
Overcoming ibrutinib resistance in mantle cell lymphoma
$450,309Alexey V. Danilov · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA